Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information.
Abubker OmaerFahad M AldosariEmily McGlamerySaad AlrashedSteven WoolMaryam T FazelPublished in: Journal of clinical pharmacy and therapeutics (2021)
Calcitonin gene-related peptide antagonists are safe and efficacious medications both in treating acute migraine headache pain and the management of episodic and chronic migraine. Head-to-head comparative studies with current guideline-recommended treatments are needed. However, CGRP antagonists are promising agents that present an alternative solution for patients living with migraine.
Keyphrases
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- copy number
- primary care
- drug induced
- genome wide
- chronic pain
- liver failure
- prognostic factors
- optic nerve
- pain management
- genome wide identification
- healthcare
- spinal cord injury
- respiratory failure
- health information
- hepatitis b virus
- patient reported outcomes
- spinal cord
- aortic dissection
- transcription factor